Common Stock, Shares, Outstanding of Marker Therapeutics, Inc. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Marker Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2010 to Q3 2025.
  • Marker Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 16.7M shares, a 87.6% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Marker Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 16.7M +7.8M +87.6% 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 11.3M +2.4M +27% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 11.2M +2.3M +25.8% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 10.7M +1.8M +20.2% 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 8.9M +100K +1.14% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 8.9M +100K +1.14% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 8.9M +100K +1.14% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 8.9M +500K +5.95% 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 8.8M -74.8M -89.5% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 8.8M -74.8M -89.5% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 8.8M -74.7M -89.5% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 8.4M +100K +1.21% 31 Dec 2022 10-K 26 Mar 2024
Q3 2022 83.6M +500K +0.6% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 83.6M +500K +0.6% 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 83.5M +500K +0.6% 31 Mar 2022 10-Q 13 May 2022
Q4 2021 8.3M -42.4M -83.6% 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 83.1M +35.1M +73.1% 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 83.1M +36.5M +78.3% 30 Jun 2021 10-Q 10 Aug 2021
Q1 2021 83M +36.5M +78.5% 31 Mar 2021 10-Q 12 May 2021
Q4 2020 50.7M +5M +10.9% 31 Dec 2020 10-K 17 Mar 2022
Q3 2020 48M +2.3M +5.03% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 46.6M +1.1M +2.42% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 46.5M +1M +2.2% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 45.7M +300K +0.66% 31 Dec 2019 10-K 09 Mar 2021
Q3 2019 45.7M +31.9M +231% 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 45.5M +31.9M +235% 30 Jun 2019 10-Q 09 Aug 2019
Q1 2019 45.5M +34.9M +329% 31 Mar 2019 10-Q 10 May 2019
Q4 2018 45.4M +34.8M +328% 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 13.8M +3.3M +31.4% 30 Sep 2018 10-Q 13 Nov 2018
Q2 2018 13.6M +3.44M +33.9% 30 Jun 2018 10-Q 09 Aug 2018
Q1 2018 10.6M +2.13M +25.1% 31 Mar 2018 10-Q 15 May 2018
Q4 2017 10.6M +2.2M +26.2% 31 Dec 2017 10-K 15 Mar 2019
Q3 2017 10.5M +2.1M +25.1% 30 Sep 2017 10-Q 14 Nov 2017
Q2 2017 10.2M -61.3M -85.8% 30 Jun 2017 10-Q 07 Aug 2017
Q1 2017 8.47M -62.5M -88.1% 31 Mar 2017 10-Q 05 May 2017
Q4 2016 8.4M +2.52M +42.8% 31 Dec 2016 10-K 23 Mar 2018
Q3 2016 8.4M -54.5M -86.7% 30 Sep 2016 10-Q 04 Nov 2016
Q2 2016 71.4M +33.4M +87.7% 30 Jun 2016 10-Q 15 Aug 2016
Q1 2016 71M +38.4M +118% 31 Mar 2016 10-Q 16 May 2016
Q4 2015 5.88M -14.4M -71% 31 Dec 2015 10-K 14 Mar 2017
Q3 2015 62.9M +43.3M +221% 30 Sep 2015 10-Q/A 14 Apr 2016
Q2 2015 38M +21.2M +126% 30 Jun 2015 10-Q/A 14 Apr 2016
Q1 2015 32.6M +16.8M +106% 31 Mar 2015 10-Q/A 14 Apr 2016
Q4 2014 20.3M +18.9M +1286% 31 Dec 2014 10-K 14 Apr 2016
Q3 2014 19.6M -125M -86.4% 30 Sep 2014 10-Q 19 Nov 2014
Q2 2014 16.8M 30 Jun 2014 10-Q 18 Aug 2014
Q1 2014 15.8M -60.6M -79.3% 31 Mar 2014 10-Q/A 21 May 2014
Q4 2013 1.47M +702K +91.8% 31 Dec 2013 10-K 15 Apr 2015
Q3 2013 144M +70.4M +95.4% 30 Sep 2013 10-Q 19 Nov 2013
Q1 2013 76.4M +22.1M +40.6% 31 Mar 2013 10-Q 19 Aug 2013
Q4 2012 764K -51.3M -98.5% 31 Dec 2012 10-K/A 17 Apr 2014
Q3 2012 73.9M +26.5M +56% 30 Sep 2012 10-Q 19 Nov 2012
Q2 2012 54.3M +7.52M +16.1% 30 Jun 2012 10-Q/A 12 Sep 2012
Q1 2012 54.3M 31 Mar 2012 10-Q 21 May 2012
Q4 2011 52.1M +11.8M +29.4% 31 Dec 2011 10-K 15 May 2013
Q3 2011 47.4M 30 Sep 2011 10-Q 21 Nov 2011
Q2 2011 46.8M 30 Jun 2011 10-Q 22 Aug 2011
Q4 2010 40.3M 31 Dec 2010 10-K 16 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.